HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Previous close
$21.69
Day range
$21.27 - $22.55
Year range
$9.12 - $72.37
Market cap
649.54M USD
Avg Volume
1.23M
P/E ratio
12.38
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 14.26M | 3,575.77% |
Operating expense | 10.13M | 3.13% |
Net income | -7.28M | 86.25% |
Net profit margin | -51.04 | 99.63% |
Earnings per share | -0.18 | 87.23% |
EBITDA | -14.99M | 74.31% |
Effective tax rate | 16.36% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 693.47M | 30.68% |
Total assets | 742.78M | 28.23% |
Total liabilities | 39.20M | -15.58% |
Total equity | 703.58M | — |
Shares outstanding | 30.47M | — |
Price to book | 1.25 | — |
Return on assets | -5.13% | — |
Return on capital | -5.32% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.28M | 86.25% |
Cash from operations | 3.25M | 110.65% |
Cash from investing | -132.00K | 65.80% |
Cash from financing | 140.00K | -99.91% |
Net change in cash | 3.26M | -97.40% |
Free cash flow | 689.00K | 104.47% |
About
Founded
2015
Headquarters
Website
Employees
82
